Detalhe da pesquisa
1.
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.
Haematologica
; 108(3): 747-760, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263840
2.
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor.
Mol Ther
; 30(3): 1215-1226, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801727
3.
Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
Blood
; 136(2): 210-223, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219444
4.
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
Haematologica
; 107(10): 2295-2303, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112552
5.
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium.
Pediatr Blood Cancer
; 69(10): e29812, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726868
6.
5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox.
Proc Natl Acad Sci U S A
; 115(8): E1867-E1875, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29432154
7.
CAR T-cell product performance in haematological malignancies before and after marketing authorisation.
Lancet Oncol
; 21(2): e104-e116, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007196
8.
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvement.
Pediatr Blood Cancer
; 67(4): e28149, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981407
9.
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(5): e28112, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31944549
10.
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia.
Blood
; 130(14): 1620-1627, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983018
11.
The American Society of Pediatric Hematology/Oncology workforce assessment: Part 1-Current state of the workforce.
Pediatr Blood Cancer
; 65(2)2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29068564
12.
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
Pediatr Blood Cancer
; 65(9): e27265, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29797659
13.
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.
Blood
; 125(5): 784-92, 2015 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25452614
14.
Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting.
Pediatr Hematol Oncol
; 34(6-7): 349-354, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29120691
15.
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.
Biol Blood Marrow Transplant
; 22(12): 2149-2154, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634018
16.
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Lancet
; 385(9967): 517-528, 2015 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25319501
17.
Immunotoxins for leukemia.
Blood
; 123(16): 2470-7, 2014 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578503
18.
Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates.
Invest New Drugs
; 34(1): 61-5, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26661090
19.
Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias.
Pediatr Blood Cancer
; 63(6): 997-1005, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891067
20.
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.
Pediatr Blood Cancer
; 68(1): e28574, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32959985